Depreciation in USD of Transcode Therapeutics, Inc. from Q1 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Transcode Therapeutics, Inc. quarterly/annual Depreciation history and change rate from Q1 2021 to Q1 2025.
  • Transcode Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $13.4K, a 58.2% decline year-over-year.
  • Transcode Therapeutics, Inc. annual Depreciation for 2024 was $90.9K, a 26.4% decline from 2023.
  • Transcode Therapeutics, Inc. annual Depreciation for 2023 was $123K, a 25.2% increase from 2022.
  • Transcode Therapeutics, Inc. annual Depreciation for 2022 was $98.6K, a 132% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Transcode Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $13.4K -$18.7K -58.2% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q1 2024 $32.2K +$2.52K +8.52% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q1 2023 $29.6K +$8.04K +37.2% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q1 2022 $21.6K +$20.3K +1623% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q1 2021 $1.25K 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022

Transcode Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $90.9K -$32.6K -26.4% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 $123K +$24.9K +25.2% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 $98.6K +$56.1K +132% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 $42.5K 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.